BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Cervical cancer AND MTOR, FRAP2, FRAP1, 2475, ENSG00000198793, P42345, RAPT1, RAFT1, FRAP, FLJ44809 AND Prognosis
34 results:

  • 1. Circular RNAs and cervical cancer: friends or foes? A landscape on circRNA-mediated regulation of key signaling pathways involved in the onset and progression of HPV-related cervical neoplasms.
    Heydarnia E; Dorostgou Z; Hedayati N; Mousavi V; Yahyazadeh S; Alimohammadi M; Gheibi M; Heidari P; Igder S; Mafi A; Vakili O
    Cell Commun Signal; 2024 Feb; 22(1):107. PubMed ID: 38341592
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Invasive stratified mucin-producing carcinoma (ISMC) of the cervix: a clinicopathological and molecular analysis of 59 cases with special emphasis on histogenesis and potential therapeutic targets.
    Yao Y; Wang Y; Ye L; Lu B; Lu W
    Histopathology; 2024 Jan; 84(2):315-324. PubMed ID: 37735961
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Kaposi sarcoma at the base of the tongue in a renal transplant patient.
    Safia A; Farhat R; Avraham Y; Merchavy S
    BMJ Case Rep; 2023 Mar; 16(3):. PubMed ID: 36882263
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Mechanistic analysis of endothelial lipase G promotion of the occurrence and development of cervical carcinoma by activating the phosphatidylinositol-4,5-bisphosphate 3-kinase/protein kinase B/mechanistic target of rapamycin kinase signalling pathway.
    Huang J; Liu R; Zhang Y; Sheng X
    J Obstet Gynaecol; 2023 Dec; 43(1):2151353. PubMed ID: 36606668
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Fatty acid synthase (FASN) inhibits the cervical squamous cell carcinoma (CESC) progression through the Akt/mtor signaling pathway.
    Lin Q; Jiang Y; Zhou F; Zhang Y
    Gene; 2023 Jan; 851():147023. PubMed ID: 36375657
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. ROS generation attenuates the anti-cancer effect of CPX on cervical cancer cells by inducing autophagy and inhibiting glycophagy.
    Fan H; He Y; Xiang J; Zhou J; Wan X; You J; Du K; Li Y; Cui L; Wang Y; Zhang C; Bu Y; Lei Y
    Redox Biol; 2022 Jul; 53():102339. PubMed ID: 35636017
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Receptor for activated C kinase 1 promotes cervical cancer lymph node metastasis via the glycolysis‑dependent AKT/mtor signaling.
    Xu L; Li J; Tursun M; Hai Y; Tursun H; Mamtimin B; Hasim A
    Int J Oncol; 2022 Jul; 61(1):. PubMed ID: 35616137
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Identification of novel key regulatory lncRNAs in gastric adenocarcinoma.
    Razavi H; Katanforosh A
    BMC Genomics; 2022 May; 23(1):352. PubMed ID: 35525925
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. G6PC indicated poor prognosis in cervical cancer and promoted cervical carcinogenesis in vitro and in vivo.
    Zhu K; Deng C; Du P; Liu T; Piao J; Piao Y; Yang M; Chen L
    Reprod Biol Endocrinol; 2022 Mar; 20(1):50. PubMed ID: 35277194
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. PLAC1 is an independent predictor of poor survival, and promotes cell proliferation and invasion in cervical cancer.
    Chen R; Sheng C; Ma R; Zhang L; Yang L; Chen Y
    Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34523695
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. LINC00861 inhibits the progression of cervical cancer cells by functioning as a ceRNA for miR‑513b‑5p and regulating the PTEN/AKT/mtor signaling pathway.
    Liu H; Zhang L; Ding X; Sui X
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179755
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers.
    Zhang C; Ren X; Zhang W; He L; Qi L; Chen R; Tu C; Li Z
    Bioengineered; 2020 Dec; 11(1):1112-1123. PubMed ID: 33124951
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. LncRNA GHET1 promotes cervical cancer progression through regulating AKT/mtor and Wnt/β-catenin signaling pathways.
    Liu Z; Luo S; Wu M; Huang C; Shi H; Song X
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31682716
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy.
    Zammataro L; Lopez S; Bellone S; Pettinella F; Bonazzoli E; Perrone E; Zhao S; Menderes G; Altwerger G; Han C; Zeybek B; Bianchi A; Manzano A; Manara P; Cocco E; Buza N; Hui P; Wong S; Ravaggi A; Bignotti E; Romani C; Todeschini P; Zanotti L; Odicino F; Pecorelli S; Donzelli C; Ardighieri L; Angioli R; Raspagliesi F; Scambia G; Choi J; Dong W; Bilguvar K; Alexandrov LB; Silasi DA; Huang GS; Ratner E; Azodi M; Schwartz PE; Pirazzoli V; Stiegler AL; Boggon TJ; Lifton RP; Schlessinger J; Santin AD
    Proc Natl Acad Sci U S A; 2019 Nov; 116(45):22730-22736. PubMed ID: 31624127
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Clinicopathological characteristics and molecular abnormalities of primary grade 2 neuroendocrine tumors of the cervix.
    Zhu R; Wu H; Chen B; Pang J; Huo Z
    Diagn Pathol; 2019 Jun; 14(1):64. PubMed ID: 31228945
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. MicroRNA-23b suppresses cervical cancer biological progression by directly targeting six1 and affecting epithelial-to-mesenchymal transition and AKT/mtor signaling pathway.
    Li YM; Li XJ; Yang HL; Zhang YB; Li JC
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4688-4697. PubMed ID: 31210295
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The NQO1/PKLR axis promotes lymph node metastasis and breast cancer progression by modulating glycolytic reprogramming.
    Yang Y; Zhu G; Dong B; Piao J; Chen L; Lin Z
    Cancer Lett; 2019 Jul; 453():170-183. PubMed ID: 30954648
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Repression of Human Papillomavirus Oncogene Expression under Hypoxia Is Mediated by PI3K/mtorC2/AKT Signaling.
    Bossler F; Kuhn BJ; Günther T; Kraemer SJ; Khalkar P; Adrian S; Lohrey C; Holzer A; Shimobayashi M; Dürst M; Mayer A; Rösl F; Grundhoff A; Krijgsveld J; Hoppe-Seyler K; Hoppe-Seyler F
    mBio; 2019 Feb; 10(1):. PubMed ID: 30755508
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Fibulin-3 knockdown inhibits cervical cancer cell growth and metastasis in vitro and in vivo.
    Li J; Qi C; Liu X; Li C; Chen J; Shi M
    Sci Rep; 2018 Jul; 8(1):10594. PubMed ID: 30006571
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Increased expression of FHL2 promotes tumorigenesis in cervical cancer and is correlated with poor prognosis.
    Jin X; Jiao X; Jiao J; Zhang T; Cui B
    Gene; 2018 Aug; 669():99-106. PubMed ID: 29800735
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.